Shlevin Harold H. — SEC Form 4 filings
SEC reporting owner CIK 1557082. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-12-31 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 6,500 shares, $7,540 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 14 legs across 4 filings — 258,499 shares, $1,555,834 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 35,000 shares @ $6.02 ($210,665) in GALECTIN THERAPEUTICS INC, filed 2025-12-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | Director | 7 | 1 leg · 6,500 sh · $7,540 | 14 legs · 258,499 sh · $1,555,834 | 26 |
Form 4 filings — Shlevin Harold H.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 7,732 @ $1.23 · Sale (S): 7,732 @ $5 · Option exercise (M): 22,268 @ $1.23 · Sale (S): 22,268 @ $5.04 · Option exercise (M): 7,732 (derivative) @ $0 · Option exercise (M): 22,268 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 20,000 @ $1.98 · Sale (S): 19,793 @ $7.04 · Sale (S): 4,706 @ $7.04 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 19,793 @ $4.16 · Sale (S): 19,793 @ $6.27 · Option exercise (M): 8,417 @ $4.16 · Sale (S): 8,417 @ $6.30 · Option exercise (M): 19,793 (derivative) @ $0 · Option exercise (M): 8,417 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Sale (S): 4,000 @ $6.00 · Option exercise (M): 35,000 @ $2.86 · Sale (S): 35,000 @ $5.95 · Option exercise (M): 20,000 @ $2.11 · Sale (S): 20,000 @ $5.96 · Option exercise (M): 20,000 @ $1.98 · +16 more | EDGAR |
| 2025-01-30 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 6,500 @ $1.16 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →